Coffee Holding (JVA) Q3 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2025 earnings summary
3 Mar, 2026Executive summary
Net sales increased 20% year-over-year for the nine months ended July 31, 2025, and reached $23.9M for Q3, up 27% year-over-year.
Gross profit margin remained flat at 19.4% for the nine-month period, but Q3 margin dropped to 12.2% due to higher costs and trading losses.
Net income for the nine months was $591,898, while Q3 saw a net loss of $1,205,413, primarily due to a $2.2M negative impact from derivative positions.
The acquisition of Empire Coffee Company contributed to higher operating expenses and added $3.2 million in revenue but resulted in a $694,130 loss; Second Empire recorded a profit in July and is expected to be accretive.
Operations remained strong despite market volatility and challenging industry conditions.
Financial highlights
Net sales for the nine months ended July 31, 2025: $68.5 million, up from $57.3 million year-over-year; Q3 net sales: $23.9M, up 27% year-over-year.
Gross profit for the nine months: $13.3 million (19.4% margin); Q3 gross profit: $2.9 million (12.2% margin).
Net income for nine months: $591,898 ($0.10 per share); Q3 net loss: $1,205,413 ($0.21 loss per share), driven by $2.2M in derivative losses.
Operating expenses rose to $11.9 million for nine months, up $2.1 million year-over-year, mainly due to the Empire Coffee acquisition.
Cash used in operations for nine months: $5.4 million, compared to $5.2 million provided in the prior year.
Outlook and guidance
Management expects to fund operations for at least the next twelve months through operating cash flow and credit facility availability.
Inventory increases are intended to support anticipated sales growth and have secured positions through 2025.
Expectation of a reversal of unrealized derivative losses in Q4, potentially boosting profits; anticipated dividend based on year-end profits.
Latest events from Coffee Holding
- Net sales and net income per share rose sharply, driven by acquisitions and operational efficiencies.JVA
Q1 202617 Mar 2026 - Q3 2024 saw 19% sales growth, margin expansion, and a return to profitability.JVA
Q3 20243 Mar 2026 - Net sales up 15% and profitability restored, with strong outlook for 2025 amid cost controls.JVA
Q4 20243 Mar 2026 - Net sales and EPS rose 9% and tripled, with improved margins and positive net income.JVA
Q1 20253 Mar 2026 - EPS up to $0.11, sales and margins rose, annual dividend resumed, risks and remediation ongoing.JVA
Q2 20253 Mar 2026 - Revenue up 23% to $96.3M, but net income per share dropped to $0.25 amid integration losses.JVA
Q4 20253 Mar 2026 - Shelf registration enables up to $30M in securities for growth and strategic flexibility.JVA
Registration Filing3 Mar 2026 - Sales and profitability improved, but going concern risk remains due to credit renewal uncertainty.JVA
Q2 20243 Mar 2026 - Registering up to $30M in securities to fund growth, acquisitions, and brand expansion.JVA
Registration Filing3 Mar 2026